Literature DB >> 19917410

The effects of C-reactive protein, interleukin-6, and tumor necrosis factor-alpha in rat allograft adventitial inflammation and allograft arteriosclerosis.

H Sun1, X Lu, S Wu, W Sun.   

Abstract

This study was designed to investigate the role of C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) during allograft adventitial inflammation and arteriosclerosis. Lewis rats were used as donors and Wistar rats as recipients for the experimental groups, while both donors and recipients were Wistar rats in the control groups. The 36 experimental and 16 control allografts were divided into four groups (nine in each experimental and four in each control group): group A animals were euthanized at 1 week posttransplantation; groups B, C, and D animals were euthanized at 2, 3, and 4 weeks posttransplantation, respectively. The method of enzyme-linked immunosorbent assay (ELISA) was used to test serum levels of CRP, IL-6, and TNF-alpha. Immunohistological and pathological studies were performed to evaluate allograft adventitial inflammation, arteriosclerosis, and expression of proliferating cell nuclear antigen (PCNA). Allografts collected from group D demonstrated abundant infiltration of smooth muscle cells and collagenous fibers with inflammatory cells in the adventitia. ELISA demonstrated a higher levels of CRP, IL-6, and TNF-alpha in experimental than control groups. Additionally, PCNA increased over time in the adventitia. Our results suggested that the expressions of CRP, IL-6, and TNF-alpha play important roles during the development of allograft adventitial inflammation and arteriosclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19917410     DOI: 10.1016/j.transproceed.2009.06.190

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

Review 1.  Mechanism of arterial remodeling in chronic allograft vasculopathy.

Authors:  Qichang Zheng; Shanglong Liu; Zifang Song
Journal:  Front Med       Date:  2011-10-02       Impact factor: 4.592

2.  Abnormally expressed miR-23b in Chinese Mongolian at high cardiovascular risk may contribute to monocyte/macrophage inflammatory reaction in atherosclerosis.

Authors:  Li-Ping He; Xing-Sheng Zhao; Le-Ping He
Journal:  Biosci Rep       Date:  2018-11-15       Impact factor: 3.840

3.  CXCR4 Antagonist Reduced the Incidence of Acute Rejection and Controlled Cardiac Allograft Vasculopathy in a Swine Heart Transplant Model Receiving a Mycophenolate-based Immunosuppressive Regimen.

Authors:  Wan-Tseng Hsu; Cheng-Hsin Lin; Hsiang-Yiang Jui; Ya-Hsuan Tseng; Chia-Tung Shun; Ming-Chu Hsu; Kenneth Kun-Yu Wu; Chii-Ming Lee
Journal:  Transplantation       Date:  2018-12       Impact factor: 4.939

4.  A Role for Peroxisome Proliferator-Activated Receptor Gamma Agonists in Counteracting the Degeneration of Cardiovascular Grafts.

Authors:  Anna Kathrin Assmann; Daniel Goschmer; Yukiharu Sugimura; Agunda Chekhoeva; Mareike Barth; Alexander Assmann; Artur Lichtenberg; Payam Akhyari
Journal:  J Cardiovasc Pharmacol       Date:  2021-10-15       Impact factor: 3.271

Review 5.  Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function.

Authors:  Yu Ding; Yongwen Zhou; Ping Ling; Xiaojun Feng; Sihui Luo; Xueying Zheng; Peter J Little; Suowen Xu; Jianping Weng
Journal:  Theranostics       Date:  2021-09-09       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.